Here is the reason why INVO Bioscience Inc. (NASDAQ: INVO) shares are up at After-Market.
INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company specializing in creating simplified, affordable treatments and commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell, for patients diagnosed with infertility, will report financial results for its first quarter 2021, completed on March 31, 2021, after the market close on May 17th. INVO stock price soared adjacent to the […]